Business Standard

Dr Reddy's gains 6% post September quarter results

The stock gained 6.5% to Rs 2,559 after the company reported a good operational performance in September quarter, on account of lower R&D, higher other income, financial income, and lower tax.

Dr Reddy's
Premium

SI Reporter Mumbai
Shares of Dr Reddy’s Laboratories have gained 6.5% to Rs 2,559 on the BSE in intra-day trade so far after the company reported a good operational performance in September quarter (Q2FY19), on account of lower R&D, higher other income, financial income, and lower tax.

Earnings before interest, tax, depreciation and amortization (Ebitda) margin of the drug maker improved by 340 bps at 22.8% in Q2FY19 from 19.4% in Q2FY18. In Q1FY19, Ebitda stood at 19.4%.

“The year-on-year (Y-o-Y) improvement in gross margin primarily aided by contribution from new launches, improved leverage, better product mix coupled with favorable foreign

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 29 2018 | 10:10 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com